mRNA expression of Galectin-9 on CD8+ T-cells in B-ALL patients was significantly lower than those in the control group (P=0.043), while VISTA expression was not significantly different between the two study groups (P=0.259). The gene discussed is LGALS9; the disease is precursor B-cell acute lymphoblastic leukemia.